Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Connect Biopharma Holdings Limited - Ordinary Shares
(NQ:
CNTB
)
1.680
+0.070 (+4.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Connect Biopharma Holdings Limited - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
May 04, 2022
It's time for another breakdown of all the biggest pre-market stock movers as we go over the news for Wednesday morning.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 03, 2022
Gainers
Via
Benzinga
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework
↗
April 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 21, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
March 11, 2022
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...
Via
Benzinga
75 Biggest Movers From Yesterday
↗
March 22, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 21, 2022
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares increased by 20.3% to $0.4 during Monday's pre-market session. The market value of their outstanding shares is at $49.7 million.
Via
Benzinga
46 Stocks Moving In Monday's Mid-Day Session
↗
March 21, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
March 21, 2022
Welcome back, investor! We're getting right into the thick of it with a look at the biggest pre-market stock movers for Monday!
Via
InvestorPlace
28 Stocks Moving in Monday's Pre-Market Session
↗
March 21, 2022
Gainers BitNile Holdings, Inc. (NYSE: NILE) rose 61.1% to $0.90 in pre-market trading. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 18, 2022
Gainers
Via
Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
↗
January 13, 2022
Key takeaways: Loss-making Connect Biopharma says Phase 3 clinical trials of its CBP-201 drug for atopic dermatitis will begin in second half of this year Connect Biopharma...
Via
Benzinga
33 Stocks Moving In Thursday's Mid-Day Session
↗
January 06, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 16, 2022
On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
58 Biggest Movers From Yesterday
↗
January 07, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
↗
January 06, 2022
JP Morgan raised the price target for RPM International Inc. (NYSE:
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
↗
January 06, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited...
Via
Benzinga
50 Biggest Movers From Yesterday
↗
January 06, 2022
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...
Via
Benzinga
34 Stocks Moving In Wednesday's Mid-Day Session
↗
January 05, 2022
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers. Data Storage...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
↗
January 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...
Via
Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
↗
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting...
Via
Talk Markets
52 Biggest Movers From Friday
↗
November 22, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second...
Via
Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
↗
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...
Via
Benzinga
Week In Review: BeiGene Cleared To Stage $3 Billion IPO On Shanghai STAR Exchange
↗
November 20, 2021
Beijing's BeiGene was approved to stage a $3 billion IPO on Shanghai’s STAR Exchange, the company's third listing. Previously, the company completed an $182 million IPO on the NASDAQ in 2016 and a $900...
Via
Talk Markets
Topics
Initial Public Offering
Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble
↗
November 19, 2021
Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69. The U.S. has...
Via
Benzinga
Topics
Stocks
Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge
↗
November 19, 2021
Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35. The U.S. has the...
Via
Benzinga
Topics
Stocks
33 Stocks Moving In Friday's Mid-Day Session
↗
November 19, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial...
Via
Benzinga
Why Connect Biopharma Stock Is Crashing Today
↗
November 19, 2021
Investors wanted more details from the company's latest clinical results.
Via
The Motley Fool
Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views
↗
November 19, 2021
Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27. The U.S....
Via
Benzinga
Topics
Stocks
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
↗
November 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.